"N Engl J Med"[journal] 检索结果

7521. Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2.

作者: Kimberly G Blumenthal.;Esther E Freeman.;Rebecca R Saff.;Lacey B Robinson.;Anna R Wolfson.;Ruth K Foreman.;Dean Hashimoto.;Aleena Banerji.;Lily Li.;Sara Anvari.;Erica S Shenoy.
来源: N Engl J Med. 2021年384卷13期1273-1277页

7522. An Uncertain Public - Encouraging Acceptance of Covid-19 Vaccines.

作者: Gillian K SteelFisher.;Robert J Blendon.;Hannah Caporello.
来源: N Engl J Med. 2021年384卷16期1483-1487页

7523. Vaccination plus Decarceration - Stopping Covid-19 in Jails and Prisons.

作者: Benjamin A Barsky.;Eric Reinhart.;Paul Farmer.;Salmaan Keshavjee.
来源: N Engl J Med. 2021年384卷17期1583-1585页

7524. Choices in a Crisis - Individual Preferences among SARS-CoV-2 Vaccines.

作者: Daniel B Kramer.;Douglas J Opel.;Efthimios Parasidis.;Michelle M Mello.
来源: N Engl J Med. 2021年384卷17期e62页

7525. Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia. Reply.

作者: John H Stone.; .
来源: N Engl J Med. 2021年384卷15期1474页

7526. Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia. Reply.

作者: Carlos Salama.;Shalini V Mohan.
来源: N Engl J Med. 2021年384卷15期1473-1474页

7527. Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia.

作者: Andreas Lundh.
来源: N Engl J Med. 2021年384卷15期1473页

7528. Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden. Reply.

作者: Jonas F Ludvigsson.
来源: N Engl J Med. 2021年384卷17期e66页

7529. Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden.

作者: Lonni Besançon.;David Steadson.;Antoine Flahault.
来源: N Engl J Med. 2021年384卷17期e66页

7530. Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden.

作者: Yoshiyasu Takefuji.
来源: N Engl J Med. 2021年384卷17期e66页

7531. Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia.

作者: Ivan O Rosas.;Norbert Bräu.;Michael Waters.;Ronaldo C Go.;Bradley D Hunter.;Sanjay Bhagani.;Daniel Skiest.;Mariam S Aziz.;Nichola Cooper.;Ivor S Douglas.;Sinisa Savic.;Taryn Youngstein.;Lorenzo Del Sorbo.;Antonio Cubillo Gracian.;David J De La Zerda.;Andrew Ustianowski.;Min Bao.;Sophie Dimonaco.;Emily Graham.;Balpreet Matharu.;Helen Spotswood.;Larry Tsai.;Atul Malhotra.
来源: N Engl J Med. 2021年384卷16期1503-1516页

Coronavirus disease 2019 (Covid-19) is associated with immune dysregulation and hyperinflammation, including elevated interleukin-6 levels. The use of tocilizumab, a monoclonal antibody against the interleukin-6 receptor, has resulted in better outcomes in patients with severe Covid-19 pneumonia in case reports and retrospective observational cohort studies. Data are needed from randomized, placebo-controlled trials.

7532. Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.

作者: .;Anthony C Gordon.;Paul R Mouncey.;Farah Al-Beidh.;Kathryn M Rowan.;Alistair D Nichol.;Yaseen M Arabi.;Djillali Annane.;Abi Beane.;Wilma van Bentum-Puijk.;Lindsay R Berry.;Zahra Bhimani.;Marc J M Bonten.;Charlotte A Bradbury.;Frank M Brunkhorst.;Adrian Buzgau.;Allen C Cheng.;Michelle A Detry.;Eamon J Duffy.;Lise J Estcourt.;Mark Fitzgerald.;Herman Goossens.;Rashan Haniffa.;Alisa M Higgins.;Thomas E Hills.;Christopher M Horvat.;Francois Lamontagne.;Patrick R Lawler.;Helen L Leavis.;Kelsey M Linstrum.;Edward Litton.;Elizabeth Lorenzi.;John C Marshall.;Florian B Mayr.;Daniel F McAuley.;Anna McGlothlin.;Shay P McGuinness.;Bryan J McVerry.;Stephanie K Montgomery.;Susan C Morpeth.;Srinivas Murthy.;Katrina Orr.;Rachael L Parke.;Jane C Parker.;Asad E Patanwala.;Ville Pettilä.;Emma Rademaker.;Marlene S Santos.;Christina T Saunders.;Christopher W Seymour.;Manu Shankar-Hari.;Wendy I Sligl.;Alexis F Turgeon.;Anne M Turner.;Frank L van de Veerdonk.;Ryan Zarychanski.;Cameron Green.;Roger J Lewis.;Derek C Angus.;Colin J McArthur.;Scott Berry.;Steve A Webb.;Lennie P G Derde.
来源: N Engl J Med. 2021年384卷16期1491-1502页

The efficacy of interleukin-6 receptor antagonists in critically ill patients with coronavirus disease 2019 (Covid-19) is unclear.

7533. Interleukin-6 Receptor Inhibition in Covid-19 - Cooling the Inflammatory Soup.

作者: Eric J Rubin.;Dan L Longo.;Lindsey R Baden.
来源: N Engl J Med. 2021年384卷16期1564-1565页

7534. Telemedicine and Medical Licensure - Potential Paths for Reform.

作者: Ateev Mehrotra.;Alok Nimgaonkar.;Barak Richman.
来源: N Engl J Med. 2021年384卷8期687-690页

7535. Gum Hypertrophy from Cyclosporine.

作者: Bina S Menon.;Kok-Hoi Teh.
来源: N Engl J Med. 2021年384卷8期744页

7536. Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment. Reply.

作者: Julio Rosenstock.;Melissa V Hansen.;Ronald Goldenberg.
来源: N Engl J Med. 2021年384卷8期e26页

7537. Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment.

作者: Viral N Shah.
来源: N Engl J Med. 2021年384卷8期e26页

7538. Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment.

作者: Yuya Suzuki.;Tianchen Zhao.;Masaharu Tsubokura.
来源: N Engl J Med. 2021年384卷8期e26页

7539. Colchicine in Patients with Chronic Coronary Disease. Reply.

作者: Aernoud T L Fiolet.;Jan H Cornel.;Peter L Thompson.
来源: N Engl J Med. 2021年384卷8期778-779页

7540. Colchicine in Patients with Chronic Coronary Disease.

作者: Domenico D'Amario.;Daniele Rodolico.;Mattia Galli.
来源: N Engl J Med. 2021年384卷8期778页

结果排序

文献格式

出版时间

出版类型

出版语言